Beyond expectations: disease duration and psychological burden in psoriatic arthritis.
Gamze KilicErkan KilicIbrahim TekeoğluBetül SarginGizem CengizNihan Cüzdan BaltaHakan AlkanSevtap Acer KasmanNilay SahinKevser GokIlknur Albayrak GezerEsra Dilek KeskinCevriye MulkogluHatice ResorluŞebnem AtamanAjda BalMehmet Tuncay DuruözOkan KucukakkasNesrin ŞenMurat ToprakOzan Volkan YurdakulMeltem Alkan MelikogluFikriye Figen AyhanMerve BaykulHatice BodurMustafa ÇalışErhan ÇapkınGul DevrimselSami HİzmetlİAyhan KamanliYasar KeskinHilal KocabaşOznur KutlukÖmer Faruk ŞendurSena Toluİsmihan SunarKemal NasPublished in: Rheumatology international (2023)
This study aims to investigate the relationship between disease duration and psychological burden in PsA and to identify the risk factors associated with psychological distress. Patients with PsA who met CASPAR classification criteria enrolled by Turkish League Against Rheumatism (TLAR)-Network. Patients were categorized into three groups based on disease duration: early stage (< 5 years), middle stage (≥ 5, < 10 years), and late stage (≥ 10 years). All patients underwent clinical and laboratory assessment using standardized protocol and case report forms. The associations between psychological variables and clinical parameters were assessed by a multivariate analysis. Of the 1113 patients with PsA (63.9% female), 564 (%50.7) had high risk for depression and 263 (%23.6) for anxiety. The risk of psychological burden was similar across all PsA groups, and patients with a higher risk of depression and anxiety also experienced greater disease activity, poorer quality of life, and physical disability. Multivariate logistic regression revealed that female gender (OR = 1.52), PsAQoL (OR = 1.13), HAQ (OR = 1.99), FiRST score (OR = 1.14), unemployment/retired (OR = 1.48) and PASI head score (OR = 1.41) were factors that influenced the risk of depression, whereas the current or past enthesitis (OR = 1.45), PsAQoL (OR = 1.19), and FiRST score (OR = 1.26) were factors that influenced the risk of anxiety. PsA patients can experience a comparable level of psychological burden throughout the course of their disease. Several socio-demographic and disease-related factors may contribute to mental disorders in PsA. In the present era of personalized treatment for PsA, evaluating psychiatric distress can guide tailored interventions that improve overall well-being and reduce disease burden.
Keyphrases
- prostate cancer
- end stage renal disease
- sleep quality
- early stage
- newly diagnosed
- chronic kidney disease
- ejection fraction
- radical prostatectomy
- disease activity
- case report
- rheumatoid arthritis
- peritoneal dialysis
- mental health
- physical activity
- systemic lupus erythematosus
- randomized controlled trial
- machine learning
- deep learning
- multiple sclerosis
- squamous cell carcinoma
- patient reported outcomes
- lymph node
- radiation therapy
- rheumatoid arthritis patients
- single cell